Reference 1 Mansour D, Walling M, Glenn D, Egarter C, Graesslin O, Herbst J, et al. Removal of non-palpable etonogestrel implants. J Fam Plann Reprod Health Care 2008; 34: 89-91. Figure 1 Disposable vasectomy forceps used for Norplant ® removal Reply We thank Anne Bennett for her comments 1 related to our article describing removal techniques for contraceptive implants. 2 Many primary care organisations are bringing in 'single-use instruments policies' as a result of new NHS guidance on decontamination aimed at improving the quality of surgical instrument reprocessing across the health care sectors in England. Finding manufacturers who are prepared to supply small numbers of specialist disposable surgical instruments is difficult, however we have good news. Disposable modified vasectomy forceps can now be obtained for about £2 from the supplier mentioned below. This company is also making disposable 'deep' implant removal kits, which include mosquito forceps and small Langenbecks skin retractors. Contact: References 1 Bennett A. Norplant removal forceps [Letter]. J Fam Plann Reprod Health Care 2008; 34: 272-273. 2 Mansour D, Walling M, Glenn D, Egarter C, Graesslin O, Herbst J, et al. Removal of non-palpable etonogestrel implants. J Fam Plann Reprod Health Care 2008; 34: 89-91.
Underuse of the IUD
I read the article on the underuse of the intrauterine device (IUD) 1 in the July issue with great interest and noted that none of the references are prior to 1983. That is 25 years ago, however the real blow to the IUD's popularity was in the late-1970s when the Dalkon Shield ® was pilloried and vilified as a source of pelvic infection and sterility, on what I believe was false scientific evidence. At that time there was a UK IUD network, organised by Professor R Snowden of Exeter University to which 20 major family planning clinics belonged.
Every device fitted and every subsequent patient visit was recorded and sent to Exeter. In 1977, over 40 000 fittings had been recorded, of which 7282 were Dalkon Shields. There were only two cases of pelvic infection and both were cases known to me in Glasgow: one in a prostitute with gonorrhoea and the other in a woman who had tried to abort herself with a knitting needle. As a direct result of organised adverse publicity, the manufacturers of the Dalkon Shield went out of business and the reputation of all IUDs worldwide suffered a slump from which it has never recovered. A similar campaign against Depo-Provera ® was mounted from the USA in the early 1980s and injectable methods never achieved the popularity they deserve for similar commercial reasons. Women are ill-served by 'market forces'. MBBS, FFSRH Family Planning Services Coordinator, Greater Glasgow Health Board 1980 -1990 
Elizabeth S B Wilson,

Nurse IUD fitting
We are writing to respond to the Personal View article by Cooling and Dunster entitled 'Nurse intrauterine device training' that was published in the July issue of the Journal. 1 We wholeheartedly applaud the positive experience expressed within this article, and its conclusion that "… nurses who are recognised trainers and experienced in IUD insertion to supervise the training of doctors" as this underpins the work the FSRH Associate Nurses Working Group has been undertaking recently. However, we felt the need to respond to the not-so-positive comments about the Royal College of Nursing (RCN) guidance being "absurd in requiring the learner to observe the trainer doing five insertions in patients: one is usually sufficient …". The RCN has been instrumental in the development of guidance in order to enhance and advance nursing practice, and has specifically demonstrated its support in enabling nurses working at a higher or specialist level within the area of contraception and sexual health to undertake the removal and insertion of intrauterine techniques (IUTs) and implants. Without this guidance, nurses who were performing these procedures, or who wished to do so, were opening themselves up to litigation should an error occur. The rationale behind the guidance stating five insertions is in the fact that some nurses (i.e. gynaecology nurses) may not have ever had the opportunity to observe an IUT fitting. It was always understood that those of us who had greater exposure to procedures would not necessarily need this level of observation.
Wendy Moore, RGN As Beth Taylor highlighted, there is certainly a need for educational and training support from specialist services in order to avoid isolation. One way of developing a robust professional link would be the development of a linked Clinical Governance Plan with local specialist services. This will not only assure a safety net but also help in continued development of such services. This would need to be thought out and planned carefully at the primary care trust (PCT) level. Moreover, treatment and patient group directions (PGDs), especially for STIs, would have to be carefully developed in the light of the recent alert on high-level azithromycin resistance in Neisseria gonorrhoea. Other issues such as partner notification would also need to be resolved through training input and professional pathway with local specialist services.
Another concern would be the prescription cost for medications, which already are free on the NHS. It would be an opportunity to work with the local PCTs to explore whether they would be willing to support some/all of the costs associated with a pharmacy site for Level 1/2 Sexual Health Service delivery. There are no data on demand for a Sexual Health Service with prescription charge. The uptake of the newly launched online chargeable repeat contraception service would give an indication of clients' willingness to pay for such services.
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